Overview

• Robert Smith, lead singer of The Cure, has been vocal against Ticketmaster's dynamic pricing, labeling it a 'scam' driven by greed.
• The band avoided dynamic pricing on their 2023 tour, opting for non-transferable tickets to prevent scalping and ensure affordability.
• Smith's advocacy led to partial refunds for fans affected by high service fees during The Cure's recent tour.
• He emphasizes the importance of fair pricing, arguing that lower ticket costs lead to happier fans who are more likely to return.
• The Cure is set to release their first album in 16 years, 'Songs of a Lost World,' on November 1, 2024.